Therapeutic Asset Ratings
204 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Abemaciclib
Non Small Cell Lung Cancer
Tango Therapeutics, Inc.
P3
B
(60)
Capecitabine
Non Small Cell Lung Cancer
BOE Technology Group Co., Ltd.
P3
B
(60)
Folic Acid
Non Small Cell Lung Cancer
AstraZeneca
P3
B
(60)
Tgrx-326
Non Small Cell Lung Cancer
Shenzhen TargetRx Co., Ltd.
P3
B
(60)
Zimberelimab
Non Small Cell Lung Cancer
Fundación GECP
P3
B
(60)
AZD9291
Non Small Cell Lung Cancer
Shandong Cancer Hospital and Institute
P3
B
(59)
Para-Toluenesulfonamide
Non Small Cell Lung Cancer
Gang Hou
P3
B
(59)
qlc1101
Non Small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.
P3
B
(59)
Adagrasib
Non Small Cell Lung Cancer
M.D. Anderson Cancer Center
P3
B
(58)
Avelumab
Non Small Cell Lung Cancer
Fate Therapeutics
P3
B
(58)
TAMOXIFEN
Non Small Cell Lung Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
P3
B
(58)
Everolimus
Non Small Cell Lung Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.
P2
B
(58)
TIL
Non Small Cell Lung Cancer
Tianjin Medical University General Hospital
P2
B
(58)
Cobicistat
Non Small Cell Lung Cancer
Maastricht University Medical Center
P4
B
(57)
Cobalamin
Non Small Cell Lung Cancer
AstraZeneca
P3
B
(57)
IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL CAN04 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL CAN04 .KAPPA.-CHAIN, DIMER
Non Small Cell Lung Cancer
Cantargia AB
P1/2
B
(57)
ABT-700-VCMMAE
Non Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center
P3
B
(56)
aciclovir
Non Small Cell Lung Cancer
Candel Therapeutics, Inc.
P3
B
(56)
Adv-Tk
Non Small Cell Lung Cancer
Candel Therapeutics, Inc.
P3
B
(56)
Anlotinib Hydrochloride Capsules
Non Small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
B
(56)
Domvanalimab
Non Small Cell Lung Cancer
Gilead Sciences
P3
B
(56)
ds-6051b
Non Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
P3
B
(56)
Fhnd-9041
Non Small Cell Lung Cancer
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
P3
B
(56)
Gotistobart
Non Small Cell Lung Cancer
OncoC4, Inc.
P3
B
(56)
Metformin
Non Small Cell Lung Cancer
Instituto Nacional de Cancerologia de Mexico
P3
B
(56)
Showing 26 to 50 of 204 assets
Previous
Page 2 of 9
Next
